Sharps Technology Inc., a U.S. maker of smart-safety syringes, said it has priced a private investment in public equity of more than $400 million as it pivots to a digital-asset treasury strategy centered on Solana’s native token, SOL. Units in the offering are priced at $6.50 and include three-year warrants exercisable at $9.75. The transaction, led by Cantor Fitzgerald with Aegis Capital as co-placement agent, is scheduled to close around Aug. 28 subject to customary conditions. Sharps intends to use most of the proceeds to acquire SOL and establish what it calls the world’s largest corporate Solana treasury. The company signed a memorandum of understanding with the Solana Foundation to purchase $50 million of SOL at a 15% discount to the 30-day average price once the public offering is completed. Investors in the PIPE include digital-asset specialists ParaFi, Pantera and Monarq. Management said the move will diversify Sharps’ balance sheet and generate on-chain yield while maintaining capital for general corporate purposes. The offering marks one of the largest treasury-focused crypto financings by a publicly traded U.S. healthcare company to date.